Adaptive Biotechnologies Corporation share price logo

Adaptive Biotechnologies Corporation

NASDAQ: ADPT

Mid Cap

$17.53

+0.75

(+4.47%)

as on

Adaptive Biotechnologies Corporation Stock Performance

as on June 19, 2026 at 2:15 pm IST

  • Day's Low

    Day's High

    $17.00
    $17.54
    downward going graph

    3.02%

    Downside

    0.06%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $9.96
    $20.76
    downward going graph

    43.21%

    Downside

    18.43%

    Upside

    downward going graph

Adaptive Biotechnologies Corporation share price movements today

Previous Close
$16.78
Open
$17.06
Volume
2.0M
Day's Low - High
$17.00 - $17.54
52 Week Low - High
$9.96 - $20.76

Adaptive Biotechnologies Corporation Historical Returns

1 Month Return
+ 35.26 %
3 Month Return
+ 29.85 %
1 Year Return
+ 67.43 %
3 Year Return
+ 108.94 %
5 Year Return
-55.56 %

Adaptive Biotechnologies Corporation Stock Fundamentals & Key Indicators

Check Adaptive Biotechnologies Corporation market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$2.7B

EPS (TTM)

-0.4573

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

0

PEG Ratio

0

EBITDA

-29.8M

Revenue (TTM)

295.4M

Profit Margin

-16.82%

Return On Equity TTM

-23.96%

Adaptive Biotechnologies Corporation vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Adaptive Biotechnologies Corporation with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
Adaptive Biotechnologies Corporation image
Adaptive Biotechnologies Corporation
BUY$2.7B-55.56%NA-16.82%NA
IDEXX Laboratories Inc. image
IDEXX Laboratories Inc.
BUY$43.1B-6.48%40.2124.63%NA
Agilent Technologies Inc. image
Agilent Technologies Inc.
BUY$35.1B-12.38%24.9719.55%0.7799999999999999%
Thermo Fisher Scientific Inc. image
Thermo Fisher Scientific Inc.
BUY$171.6B-3.7%25.3715.15%0.37%
Danaher Corporation image
Danaher Corporation
BUY$125.8B-31.05%34.3814.89%0.75%

Stock Returns calculator for Adaptive Biotechnologies Corporation Stock including INR - Dollar returns

The Adaptive Biotechnologies Corporation stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

Adaptive Biotechnologies Corporation investment value today

Current value as on today

₹1,81,832

Returns

₹81,832

(+81.83%)

Returns from Adaptive Biotechnologies Corporation Stock

₹67,431 (+67.43%)

Dollar Impact

₹14,401 (+14.4%)

Analyst Recommendation on Adaptive Biotechnologies Corporation Stock

Based on 14 analysts

BUY

78.57%

Buy

21.43%

Hold

0.00%

Sell

Based on 14 analysts, 78.57% of analysts recommend a 'BUY' rating for Adaptive Biotechnologies Corporation. Average target price of $20.14

Adaptive Biotechnologies Corporation Share Price Target

Get share price movements and forecasts by analysts on Adaptive Biotechnologies Corporation.

What analysts predicted

12.96%UPSIDE

Target Price

$20.14

Current Price

$17.53

Analyzed by

14 Analysts

Target

$20.14

Adaptive Biotechnologies Corporation target price $20.14, a slight upside of 12.96% compared to current price of $17.53. According to 14 analysts rating.

Indian Investors' Interest in Adaptive Biotechnologies Corporation Stock

Search interest for Adaptive Biotechnologies Corporation Stock has increased by 2443% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:2443% versus previous 30 day period

Adaptive Biotechnologies Corporation Quarterly Profit & Loss

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Total Revenue
45
41
43
46
47
52
58
93
71
70
Gross Profit
26
23
23
29
29
35
40
75
53
52
Operating Income
-71
-48
-47
-32
-33
-29
-25
10
-12
-19
EBITDA
-61
-39
-38
-24
-26
-29
-18
16
-6
-14
Interest Expense
3
2
2
2
2
2
2
2
2
2
Depreciation
5
5
5
4
4
4
4
4
4
3
Income Before Tax
-69
-47
-46
-32
-33
-29
-25
9
-13
-20
Income Tax Expense
0
4
0
-
-
-
-
-
-
-
Net Income
-69
-47
-46
-32
-33
-29
-25
9
-13
-20
Net Profit Margin
-151.67%
-113.45%
-107.02%
-69.07%
-70.99%
-56.92%
-43.50%
10.16%
-18.94%
-28.27%

Adaptive Biotechnologies Corporation Annual Profit & Loss

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
38
55
85
98
154
185
170
178
276
Gross Profit
22
35
62
75
105
127
94
106
205
Operating Income
-44
-49
-78
-152
-208
-200
-227
-162
-57
EBITDA
-37
-43
-70
-144
-193
-175
-189
-128
-29
Interest Expense
-
-
-
-
1
4
13
11
11
Depreciation
5
6
7
8
13
20
22
19
17
Income Before Tax
-42
-46
-68
-146
-207
-200
-225
-159
-59
Income Tax Expense
0
3
-9
-6
-1
-57
0
-
-
Net Income
-42
-46
-68
-146
-207
-200
-225
-159
-59
Net Profit Margin
-111.40%
-83.44%
-80.65%
-148.63%
-134.30%
-108.03%
-132.29%
-89.12%
-21.48%

Adaptive Biotechnologies Corporation Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Net Income
-47
-46
-32
-33
-29
-25
9
-13
-20
Operating Cash Flow
-38
-17
-27
-12
-28
-12
-7
2
-9
Investing Cash Flow
44
5
5
22
25
3
17
-8
9
Financing Cash Flow
0
0
0
0
5
1
1
21
7
Change in Cash
6
-11
-21
9
2
-7
11
15
7

Adaptive Biotechnologies Corporation Annual Cash Flow

All numbers in Millions USD

Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-46
-68
-146
-207
-200
-225
-159
-59
Operating Cash Flow
-32
205
-149
-192
-183
-156
-95
-45
Investing Cash Flow
0
-481
-117
181
2
129
77
37
Financing Cash Flow
1
319
293
27
132
2
0
30
Change in Cash
-30
43
26
15
-49
-24
-17
22

Global Institutional Holdings in Adaptive Biotechnologies Corporation

Funds
Holdings
Wellington Management Company LLP
2.41%
ING Investment Management LLC
1.02%
State Street Corp
2.02%
Westfield Capital Management Company, L.P.
3.4%
Iron Triangle Partners LP
0.98%
See all

Adaptive Biotechnologies Corporation News & Key Events

  • img

    Today's Timeline - 17 June

    Wed, 03:30 PM

    -

    Adaptive Biotechnologies prices $300 million convertible senior notes to enhance financial flexibility and fund share repurchases.

    Wed, 10:51 PM

    -

    Adaptive Biotechnologies' stock declines as analysts discuss separation plan for Immune Medicine, potentially simplifying investment focus on MRD business.

Insights on Adaptive Biotechnologies Corporation

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Best in 3 Years

    img

    In the last 3 years, ADPT has outperformed top 5 stocks with highest market-cap in its industry

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 1 month, ADPT stock has moved up by 25.6%

  • imgPOSITIVE IMPACT

    Best in 1 Year

    img

    In the last 1 year, ADPT has outperformed top 5 stocks with highest market-cap in its industry

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 3 quarters, 9.54M → -20.03M (in $), with an average decrease of 144.9% per quarter

  • imgNEGATIVE IMPACT

    Revenue Fall

    img

    Revenue is down for the last 3 quarters, 93.97M → 70.87M (in $), with an average decrease of 12.4% per quarter

About Adaptive Biotechnologies Corporation

Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunosequencing platform which combines a suite of proprietary chemistry, computational biology, and machine learning to generate clinical immunomics data to decode the adaptive immune system. It provides clonoSEQ diagnostic test which detects and monitors the remaining number of cancer cells that are present in a patient's body during and after treatment, known as Minimal Residual Disease (MRD). The company offers products and services for life sciences research, clinical diagnostics, and drug discovery applications. The company was formerly known as Adaptive TCR Corporation and changed its name to Adaptive Biotechnologies Corporation in December 2011. Adaptive Biotechnologies Corporation was incorporated in 2009 and is headquartered in Seattle, Washington.
OrganisationAdaptive Biotechnologies Corporation
Headquarters1165 Eastlake Avenue East, Seattle, WA, United States, 98109
IndustryDiagnostics & Research
CEOMr. Chad M. Robins M.B.A.
E-voting on sharesClick here to vote

Key Management of Adaptive Biotechnologies Corporation

Name

Title

Mr. Kyle Piskel

VP, CFO & Principal Accounting Officer

Mr. Francis T. Lo

Chief People Officer

Dr. Sharon Benzeno Ph.D.

Chief Commercial Officer of Immune Medicine

Mr. Chad M. Robins M.B.A.

Co-Founder, CEO & Chairman

Ms. Julie Rubinstein

President & COO

Dr. Harlan S. Robins Ph.D.

Co-Founder & Chief Scientific Officer

Ms. Susan Bobulsky

Chief Commercial Officer of MRD

Mr. Christopher Carlson Ph.D.

Founder

Ms. Karina Calzadilla

Vice President of Investor Relations

Ms. Clarice McCauley

Head of Legal, Corporate Secretary, VP & Chief Compliance Officer

FAQs

What is Adaptive Biotechnologies Corporation share price today?

Adaptive Biotechnologies Corporation share price today is $17.53 as on at the close of the market. Adaptive Biotechnologies Corporation share today touched a day high of $17.54 and a low of $17.

What is the 52 week high and 52 week low for Adaptive Biotechnologies Corporation share?

Adaptive Biotechnologies Corporation share touched a 52 week high of $20.76 on and a 52 week low of $9.96 on . Adaptive Biotechnologies Corporation stock price today i.e. is closed at $17.53,which is 15.56% down from its 52 week high and 76.09% up from its 52 week low.

What is Adaptive Biotechnologies Corporation's market capitalisation today?

Adaptive Biotechnologies Corporation market capitalisation is $0.00T as on .

How to invest in Adaptive Biotechnologies Corporation Stock (ADPT) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Adaptive Biotechnologies Corporation on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Adaptive Biotechnologies Corporation Shares that will get you 0.0856 shares as per Adaptive Biotechnologies Corporation share price of $17.53 per share as on June 19, 2026 at 8:45 am IST.

What is the minimum amount required to buy Adaptive Biotechnologies Corporation Stock (ADPT) from India?

Indian investors can start investing in Adaptive Biotechnologies Corporation (ADPT) shares with as little as ₹94.31 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹943.10 in Adaptive Biotechnologies Corporation stock (as per the Rupee-Dollar exchange rate as on ). Based on Adaptive Biotechnologies Corporation share’s latest price of $17.53 as on June 19, 2026 at 8:45 am IST, you will get 0.5705 shares of Adaptive Biotechnologies Corporation. Learn more about fractional shares .

What are the returns that Adaptive Biotechnologies Corporation has given to Indian investors in the last 5 years?

Adaptive Biotechnologies Corporation stock has given -55.56% share price returns and 27.56% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?